RecruitingNot ApplicableNCT07470723

The ORIGIN-FH Study

Opportunity to Reach Individuals With Genetic Dyslipidemia During Infancy and the Newborn Period to Find Familial Hypercholesterolemia

Sponsor

University of Wisconsin, Madison

Enrollment

70 participants

Start Date

Feb 14, 2026

Study Type

INTERVENTIONAL

Conditions

Homozygous Familial Hypercholesterolemia (HoFH)Familial Hypercholesterolemia Heterozygous Familial Hypercholesterolemia (HeFH)

Summary

The goal of this clinical trial is to identify different types of Familial Hypercholesterolemia (FH) in infants and newborns. Participants will: * undergo a cheek swab for genetic testing (parents only) * have 5 blood samples collected Participants can expect to be in the trial for 2 years.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Screening for FH for people with familial hypercholesterolemia, heterozygous familial hypercholesterolemia (hefh), and other related conditions. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.